Holen Sie sich die Stockscreener-App
0.8825
1.12%
-0.01
Handel nachbörslich:
.88
-0.0025
-0.28%
Schlusskurs vom Vortag:
$0.8925
Offen:
$0.89
24-Stunden-Volumen:
18,726
Relative Volume:
0.05
Marktkapitalisierung:
$4.07M
Einnahmen:
$8.97M
Nettoeinkommen (Verlust:
$-15.21M
KGV:
-0.00757
EPS:
-116.51
Netto-Cashflow:
$-10.84M
1W Leistung:
-5.11%
1M Leistung:
-21.90%
6M Leistung:
-62.61%
1J Leistung:
-92.45%
1-Tages-Spanne:
$0.8629
$0.93
1-Wochen-Bereich:
$0.8629
$0.9345
52-Wochen-Spanne:
$0.7506
$14.00
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Vergleichen Sie NUWE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
0.8825 | 4.07M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 | NUWE Stock News - GuruFocus
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 - The Manila Times
Medical Tech Earnings: Nuwellis to Reveal Q1 2025 PerformanceKey Details for Investors - Stock Titan
Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with Strategic Growth in Critical Care - GuruFocus
Nuwellis Highlights Strategic Shift to Critical Care - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips - Investing.com India
NUWE stock touches 52-week low at $0.9 amid market challenges By Investing.com - Investing.com South Africa
NUWE stock touches 52-week low at $0.9 amid market challenges - Investing.com Australia
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised) - MSN
Nuwellis, Inc. Earnings Call: Mixed Results with Promising Prospects - TipRanks
Nuwellis, Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
Nuwellis price target lowered to $13 from $16 at Roth MKM - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips By Investing.com - Investing.com South Africa
Nuwellis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Medical device maker Nuwellis posts fourth-quarter sales of $2.3 mln -March 11, 2025 at 09:08 am EDT - Marketscreener.com
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Nuwellis reports Q4 EPS (44c) vs ($54.48) last year - TipRanks
Nuwellis Earnings Show Major Medicare Win: 4X Payment Boost Coming as Critical Care Surges - StockTitan
Nuwellis (NUWE) Projected to Post Earnings on Tuesday - Defense World
Nuwellis, Inc. to Host Earnings Call - ACCESS Newswire
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO - The Manila Times
Nuwellis Appoints John Erb as Interim CEO - MSN
Nuwellis announces CEO retirement - MSN
Nuwellis Announces Retirement Of Nestor Jaramillo, Jr. As President And CEO -February 24, 2025 at 05:07 pm EST - Marketscreener.com
Nuwellis announces leadership transition with interim CEO By Investing.com - Investing.com Canada
Nuwellis announces leadership transition with interim CEO - Investing.com India
Can Nuwellis' Former CEO Steady the Ship? Key Details of Leadership Shuffle - StockTitan
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis - The Manila Times
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow Ultrafiltration Therapy in Updated AVOID-HF Study Analysis - Nasdaq
Revolutionary Heart Failure Treatment Cuts Patient Events by 60%New Study Reveals Why It Matters - StockTitan
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - The Manila Times
Nuwellis, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - Nasdaq
Nuwellis Financial Results: Strategic Update and 2024 Performance Review Coming Next Month - StockTitan
Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Rises By 67.8% - Defense World
Nuwellis (NASDAQ:NUWE) Stock Price Up 2.4% – Here’s What Happened - Defense World
Nuwellis Inc (NUWE) produces promising results - US Post News
Market Highlights: Nuwellis Inc (NUWE) Ends on a Low Note at 1.21 - The Dwinnex
Update on Alert: Extracorporeal Blood Circuit Issue from Nuwellis - FDA.gov
Xcorporeal (OTCMKTS:XCRP) versus Nuwellis (NASDAQ:NUWE) Critical Review - Defense World
Roth Capital Has Optimistic View of Nuwellis FY2024 Earnings - Defense World
Equities Analysts Issue Forecasts for Nuwellis Q1 Earnings - Defense World
Nuwellis Stock Spikes After Reimbursement Hike: Retail’s Upbeat - MSN
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy - The Manila Times
Nuwellis Expands Pediatric Reach: Aquadex SmartFlow System Adopted by Major Utah Hospital - StockTitan
FDA issues early alert against Nuwellis’ extracorporeal blood circuits - Medical Buyer
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device - AOL
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):